The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer
- DOI
- 10.15212/amm-2022-0027
- Published
- 2022
- Container
- Acta Materia Medica
- Publisher
- Compuscript, Ltd.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.15212/amm-2022-0027,
title = {The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer},
author = {Xuewen Liu and Xin Jin and Hongling Ou and Chen Qian and Hui Wu and Chunmei Zuo and Yuliang Ren and Miaoxin Fu and Te Zhang and Liang Zhang and Yuan Si and Ying Liu},
year = {2022},
journal = {Acta Materia Medica},
doi = {10.15212/amm-2022-0027},
url = {https://doi.org/10.15212/amm-2022-0027}
}RIS
TY - JOUR TI - The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer AU - Xuewen Liu AU - Xin Jin AU - Hongling Ou AU - Chen Qian AU - Hui Wu AU - Chunmei Zuo AU - Yuliang Ren AU - Miaoxin Fu AU - Te Zhang AU - Liang Zhang AU - Yuan Si AU - Ying Liu PY - 2022 JO - Acta Materia Medica DO - 10.15212/amm-2022-0027 UR - https://doi.org/10.15212/amm-2022-0027 ER -
APA
Liu, X., Jin, X., Ou, H., Qian, C., Wu, H., Zuo, C., Ren, Y., Fu, M., Zhang, T., Zhang, L., Si, Y., & Liu, Y. (2022). The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer. Acta Materia Medica. https://doi.org/10.15212/amm-2022-0027
Source records
- crossref · retrieved 2026-09-27T04:59:35.498Z